Vectors Research Management’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Vectors Research Management’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-48	Closed	-$4K	–	141
2023 Q2	$4K	Buy	+48	New	+$3.99K	﹤0.01%	137
2023 Q1	–	Sell	-48	Closed	-$6K	–	141
2022 Q4	$6K	Hold	48	–	–	﹤0.01%	134
2022 Q3	$5K	Hold	48	–	–	﹤0.01%	135
2022 Q2	$11K	Hold	48	–	–	﹤0.01%	358
2022 Q1	$13K	Buy	48 +24	+100%	+$6.63K	﹤0.01%	329
2021 Q4	$5K	Hold	24	–	–	﹤0.01%	516
2021 Q3	$11K	Hold	24	–	–	﹤0.01%	359
2021 Q2	$14K	Hold	24	–	–	﹤0.01%	350
2021 Q1	$15K	Hold	24	–	–	﹤0.01%	307
2020 Q4	$10K	Hold	24	–	–	﹤0.01%	333
2020 Q3	$9K	Buy	+24	New	+$26.2K	﹤0.01%	308

Other funds holding VCNX

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Tacita Capital Toronto, Ontario, Canada $169M AUM 24.7% 1-Year Est. Return

Group One Trading

Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return